These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 8295172)

  • 1. Eosinophilia-myalgia syndrome: morbidity and mortality.
    Kaufman LD
    J Rheumatol; 1993 Oct; 20(10):1644-6. PubMed ID: 8295172
    [No Abstract]   [Full Text] [Related]  

  • 2. The natural history of eosinophilia-myalgia syndrome in a tryptophan-exposed cohort in South Carolina.
    Sullivan EA; Kamb ML; Jones JL; Meyer P; Philen RM; Falk H; Sinks T
    Arch Intern Med; 1996 May; 156(9):973-9. PubMed ID: 8624177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of Centers for Disease Control and Prevention criteria for the eosinophilia-myalgia syndrome in a geographically defined population.
    Spitzer WO; Haggerty JL; Berkson L; Davis W; Palmer W; Tamblyn R; Laprise R; Mulder LJ
    J Rheumatol Suppl; 1996 Oct; 46():73-9; discussion 79-80. PubMed ID: 8895183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eosinophilia-myalgia syndrome and peripheral eosinophilia.
    Schwartzberg M; Weber CA
    J Rheumatol; 1991 Dec; 18(12):1940-1. PubMed ID: 1795341
    [No Abstract]   [Full Text] [Related]  

  • 5. Eosinophilia-myalgia syndrome.
    Duffy J
    Mayo Clin Proc; 1992 Dec; 67(12):1201-2. PubMed ID: 1469933
    [No Abstract]   [Full Text] [Related]  

  • 6. Eosinophilia-myalgia syndrome: a clinicopathological study of four patients.
    Villanova M; De Clerck LS; Cras P; Ceuterick C; Van Marck E; Guazzi GC; Martin JJ
    Clin Neuropathol; 1993; 12(4):201-3. PubMed ID: 8403629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The eosinophilia-myalgia syndrome.
    Silver RM
    Clin Dermatol; 1994; 12(3):457-65. PubMed ID: 7954203
    [No Abstract]   [Full Text] [Related]  

  • 8. [L-tryptophan-induced eosinophilia-myalgia syndrome, Chinese restaurant syndrome].
    Terao T; Hori H; Nakamura J
    Ryoikibetsu Shokogun Shirizu; 1999; (27 Pt 2):650-3. PubMed ID: 10434740
    [No Abstract]   [Full Text] [Related]  

  • 9. The eosinophilia-myalgia syndrome: opportunities realized and missed.
    Hertzman PA
    J Rheumatol; 1996 Oct; 23(10):1679-81. PubMed ID: 8895138
    [No Abstract]   [Full Text] [Related]  

  • 10. Structural characterization of contaminants found in commercial preparations of melatonin: similarities to case-related compounds from L-tryptophan associated with eosinophilia-myalgia syndrome.
    Williamson BL; Tomlinson AJ; Mishra PK; Gleich GJ; Naylor S
    Chem Res Toxicol; 1998 Mar; 11(3):234-40. PubMed ID: 9544622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The eosinophilia-myalgia syndrome revisited.
    Belongia EA; Gleich GJ
    J Rheumatol; 1996 Oct; 23(10):1682-5. PubMed ID: 8895139
    [No Abstract]   [Full Text] [Related]  

  • 12. Eosinophilia-myalgia syndrome and giant cell myocarditis: a case report and therapeutic approach.
    Amidon TM; Baldwin JL; George E
    Heart Dis; 1999; 1(2):66-7. PubMed ID: 11720607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fatal eosinophilia myalgia syndrome in a marrow transplant patient attributed to total parenteral nutrition with a solution containing tryptophan.
    de Oliveira JS; Auerbach SB; Sullivan KM; Sale GE
    Bone Marrow Transplant; 1993 Feb; 11(2):163-7. PubMed ID: 8435665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A heretofore undisclosed crux of eosinophilia-myalgia syndrome: compromised histamine degradation.
    Smith MJ; Garrett RH
    Inflamm Res; 2005 Nov; 54(11):435-50. PubMed ID: 16307217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A case of eosinophilia-myalgia syndrome complicated with recurrent parotitis].
    Akiyama Y; Suzuki T; Tanaka M; Imai F; Asaoka T; Sakamoto Y; Kitamura K
    Arerugi; 1997 Dec; 46(12):1273-6. PubMed ID: 9503688
    [No Abstract]   [Full Text] [Related]  

  • 16. A contaminant of L-tryptophan enhances expression of dermal collagen in a murine model of eosinophilia myalgia syndrome.
    Suzuki S; Tourkina E; Ludwicka A; Hampton M; Bolster M; Maize J; Silver R
    Proc Assoc Am Physicians; 1996 Jul; 108(4):315-22. PubMed ID: 8863345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Eosinophilia-myalgia syndrome].
    Eisenman A; Enat R
    Harefuah; 1993 Nov; 125(9):294-5. PubMed ID: 8253425
    [No Abstract]   [Full Text] [Related]  

  • 18. Severe sclerodermalike manifestations of the eosinophilia-myalgia syndrome despite concomitant colchicine therapy.
    Lacour JP; Perrin C; Bodokh I; Ortonne JP
    Arch Dermatol; 1991 Nov; 127(11):1732-3. PubMed ID: 1952988
    [No Abstract]   [Full Text] [Related]  

  • 19. Eosinophilia-myalgia syndrome: opportunities realized and missed.
    Hess EV
    J Rheumatol; 1997 Jun; 24(6):1239-40. PubMed ID: 9195545
    [No Abstract]   [Full Text] [Related]  

  • 20. Fibromyalgia, psychiatric disorders, and assessment of the longterm outcome of eosinophilia-myalgia syndrome.
    Hudson JI; Pope HG; Carter WP; Daniels SR
    J Rheumatol Suppl; 1996 Oct; 46():37-42; discussion 42-3. PubMed ID: 8895180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.